# Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-safety-and-biomarker-analysis-of-camrelizumab-in-previously-treated/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yunpeng Yang,Ting Zhou,Xiaozhong Chen,Jingao Li,Jianji Pan,Xiaohui He,Lizhu Lin,Yingrui Shi,Weineng Feng,Jianping Xiong,Kunyu Yang,Qitao Yu,Qunling Zhang,Desheng Hu,Yan Sun,G. Hu,Ping Li,Liangfang Shen,Qin Lin,Ben Zhang,Xiao Qu,Jianjun Zou,Li Zhang,Wenfeng Fang,Yuanyuan Zhao |
| Citations | 97 |
| DOI | 10.1136/jitc-2021-003790 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://jitc.bmj.com/content/jitc/9/12/e003790.full.pdf |
| OpenAlex ID | https://openalex.org/W4200442407 |
| PMID | 34933967 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Weineng Feng](https://scholariq.org/researchers/weineng-feng/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.